Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care
Crossref DOI link: https://doi.org/10.1186/s12931-015-0295-2
Published Online: 2015-11-16
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Punekar, Yogesh Suresh
Landis, Sarah H
Wurst, Keele
Le, Hoa
Funding for this research was provided by:
GlaxoSmithKline